Plunkett Research Online: KalVista Pharmaceuticals Inc

KALVISTA PHARMACEUTICALS INC (KALV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company’s product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angi.....



KalVista Pharmaceuticals Inc
Ticker: KALV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 855-6777
Fax:
Address: One Kendall Square
Building 200, Suite 2203
Cambridge, MA 02139 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing
ContactsDescription
Thomas CrockettCEO/Director
Benjamin PalleikoCFO/Chief Accounting Officer
See More
KalVista Pharmaceuticals Inc is a pharmaceuticals company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company’s product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angi.....See More See More

Auditor: Deloitte & Touche LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: